Tango Therapeutics, Inc. Share Price
NASDAQ: TNGX | Mid CapTango Therapeutics, Inc. Stock Performance
Tango Therapeutics, Inc. Share Price Today
As of 30 October 2026, Tango Therapeutics, Inc.'s share price is $22.52. The stock opened at $22.38, compared to its previous close of $22.21. During today's trading session, Tango Therapeutics, Inc.'s share price traded between $22.38 and $23.57, with an average price of $22.98. Over the past 52 weeks, the stock has recorded a high of $34.35 and a low of $7.37. In terms of performance, Tango Therapeutics, Inc.'s share price has risen by 4.09% over the last six months and is up 177.79% on a year-on-year basis.
Tango Therapeutics, Inc. Share Price Chart
Tango Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Tango Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Tango Therapeutics, Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Tango Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $24.45 | $22.52 | -9.90% |
Sep 2026 | $22.66 | $25.00 | -1.13% |
Aug 2026 | $26.73 | $25.28 | -7.06% |
Jul 2026 | $30.93 | $27.20 | -13.06% |
Jun 2026 | $21.54 | $31.29 | +42.14% |
May 2026 | $21.33 | $22.01 | +1.76% |
Apr 2026 | $21.04 | $21.63 | +3.34% |
Mar 2026 | $10.94 | $20.93 | +87.80% |
Feb 2026 | $11.76 | $11.14 | -4.17% |
Jan 2026 | $8.88 | $11.63 | +31.19% |
Dec 2025 | $10.65 | $8.87 | -18.89% |
Nov 2025 | $7.93 | $10.93 | +34.86% |